ValiRx Share Price (VAL)
| Bid price | 0.62 | Open price | 0.65 |
|---|---|---|---|
| Ask price | 0.65 | Prev close | 0.64 |
| High price | 0.65 | Spread | 4.62% |
| Low price | 0.60 | Volume | 10,914,032 |
Register now for FREE live ValiRx share prices, ValiRx stock quotes, charts, trades and FREE ValiRx company fundamentals, market news and much much more. Why not upgrade to a premium service and get ValiRx Level 2 Data, indepth research tools and investor commentary for ValiRx (VAL) and other London Stock Exchange equities.
ValiRx Share Price Chart
Register now for FREE ValiRx share price charts
ValiRx Share Price Information
| Name | ValiRx | Epic | VAL |
|---|---|---|---|
| Activites | Provides therapeutic and diagnostic research and development | Reuters | VAL.L |
| ISIN | GB00B23N9136 | Google Finance | LON:VAL |
| Share Price (p) | 0.64 | Prev. Share Price (p) | 0.64 |
|---|---|---|---|
| Shares in Issue (m) | 1,060 | Market Cap (£m) | 7 |
| PE Ratio (x) | -1.21 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -0.20 | PEG |
Register now for FREE ValiRx company fundamentals
ValiRx Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 14/07/2011 | BUY | Satu Vainikka | CEO | 1,235,555 |
| 14/07/2011 | BUY | George Morris | ED | 538,770 |
| 14/07/2011 | BUY | Gerald Desler | FD | 538,770 |
| 14/07/2011 | BUY | Kevin Alexander | NED | 538,770 |
| 14/07/2008 | SELL | Satu Vainikka | CEO | 16,667 |
ValiRx Company News
New European patent grant for ValiRx
ValiRx, the life science company with a focus on cancer diagnostics, has announced that a cancer screening test biomarker called NAV3, one of the five patent family assets its subsidiary, ValiFinn Oy acquired from Pharmatest Services of Finland, has recently received patent approval by the...
New European Patent Grant
/* */ RNS Number : 6489W ValiRx PLC 02 February 2012 2 February 2012 ValiRx Plc ("ValiRx" or the "Company") New European Patent Grant for ValiFinn's Recently Acquired Cancer Screening Test Biomarker ...
Total Voting Rights
/* */ RNS Number : 4643W ValiRx PLC 31 January 2012 31 January 2012 ValiRx Plc ("ValiRx" or the "Company") Total Voting Rights In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the...
Register now for FREE ValiRx company news
ValiRx Share Price Discussions
"I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. lol (VAL)
Dr Satu Vainikka, CEO commented: "I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. With Chlamydia being diagnosed as the fastest growing sexually transmitted disease at the moment, our self-testing pack, as an affordable, easy -to-use...
Register now for FREE ValiRx share price discussions